Jemaa Riadh, Achouri Afef, Kallel Amani, Ben Ali Samir, Mourali Sami, Feki Moncef, Elasmi Monia, Taieb Samah Haj, Sanhaji Haïfa, Omar Souheil, Mechmeche Rachid, Kaabachi Naziha
Research Laboratory LAB-SM-01 and Department of Biochemistry, Rabta University Hospital, Tunis, Tunisia.
Clin Chem Lab Med. 2008;46(10):1364-8. doi: 10.1515/CCLM.2008.306.
Elevated plasma total homocysteine (tHcy), a risk factor for coronary artery disease (CAD), is due to defects in genes encoding for enzymes involved in tHcy metabolism or from inadequate status of vitamins involved in tHcy disposal. Methionine synthase (MS), a vitamin B(12)-dependent enzyme, catalyses the remethylation of homocysteine to methionine using a methyl group donated by 5-methyltetra-hydrofolate, which is the major circulating form of folate in the body. Functional genetic variants of the MS may alter tHcy as well as folate levels which are independent risk factors for CAD. The influence of a common genetic polymorphism 2756A>G of the MS gene (MTR) on plasma tHcy, folate and vitamin B(12) levels and its relation to the risk of myocardial infarction (MI) in a Tunisian case-control study was investigated.
A total of 321 Tunisian patients with MI and 343 healthy controls were included in the study. The 2756A>G variant of the MTR was determined by polymerase chain reaction-restriction fragment length polymorphism analysis. Plasma tHcy was assessed with a fluorescent polarising immunoassay method. Plasma vitamin B(12) and folate were determined by microparticular enzyme immunoassay and ion-capture, respectively.
A significant difference in genotype distribution and allele frequency was observed between patients and controls. Patients with MI had a frequency of 1.9% for the GG genotype, 26.2% for the AG genotype and 72% for the AA genotype. Controls had a frequency of only 0.9% for the GG genotype, 18.7% for the AG genotype and 80.5% for the AA genotype (chi(2)=6.97, p=0.03). The MI patient group showed a significant higher frequency of the G allele compared to controls (0.149 vs. 0.101; OR 1.55; 95% CI 1.10-2.18; p=0.008). The association between the 2756A>G variant in the gene encoding MS and MI was no longer significant after adjustment for other well-established risk factors. When clinical and laboratory values were compared amongst genotypes in the study groups, no significant differences were noted.
The present study showed a significant but not independent association between the 2756A>G polymorphism of the MTR (presence of G allele) and MI in the Tunisian population.
血浆总同型半胱氨酸(tHcy)升高是冠状动脉疾病(CAD)的一个危险因素,其原因是参与tHcy代谢的酶的编码基因存在缺陷,或者是参与tHcy代谢的维生素状态不足。甲硫氨酸合成酶(MS)是一种依赖维生素B12的酶,它利用5-甲基四氢叶酸提供的甲基将同型半胱氨酸重新甲基化为甲硫氨酸,5-甲基四氢叶酸是体内叶酸的主要循环形式。MS的功能性基因变异可能会改变tHcy以及叶酸水平,而这两者都是CAD的独立危险因素。在一项突尼斯病例对照研究中,研究了MS基因(MTR)常见的2756A>G基因多态性对血浆tHcy、叶酸和维生素B12水平的影响及其与心肌梗死(MI)风险的关系。
该研究共纳入321例突尼斯MI患者和343例健康对照。通过聚合酶链反应-限制性片段长度多态性分析确定MTR的2756A>G变异。采用荧光偏振免疫分析法评估血浆tHcy。分别通过微粒酶免疫分析法和离子捕获法测定血浆维生素B12和叶酸。
患者和对照之间在基因型分布和等位基因频率上存在显著差异。MI患者中GG基因型频率为1.9%,AG基因型频率为26.2%,AA基因型频率为72%。对照中GG基因型频率仅为0.9%,AG基因型频率为18.7%,AA基因型频率为80.5%(χ2 = 6.97,p = 0.03)。与对照相比,MI患者组G等位基因频率显著更高(0.149对0.101;OR 1.55;95%CI 1.10 - 2.18;p = 0.008)。在对其他已确定的危险因素进行调整后,编码MS的基因中2756A>G变异与MI之间的关联不再显著。当比较研究组中各基因型的临床和实验室值时,未发现显著差异。
本研究表明,突尼斯人群中MTR的2756A>G多态性(G等位基因的存在)与MI之间存在显著但非独立的关联。